Abstract As we learn more about the factors that govern cardiac mitochondrial bioenergetics, fission and fusion, as well as the triggers of apoptotic and necrotic cell death, there is growing appreciation that these dynamic processes are finely-tuned by equally dynamic posttranslational modification of proteins in and around the mitochondrion. In this minireview, we discuss the evidence that S-nitrosylation, glutathionylation and phosphorylation of mitochondrial proteins have important bioenergetic consequences. A full accounting of these targets, and the functional impact of their modifications, will be necessary to determine the extent to which these processes underlie ischemia/reperfusion injury, cardioprotection by pre/post-conditioning, and the pathogenesis of heart failure.
Introduction
Mitochondria are the sites of aerobic metabolism where energy in the form of nutrition is converted to a more usable energy currency, ATP. A hallmark of mitochondrial function in the heart is its ability to step-up ATP production promptly in response to increased workloads. Failure to do so has disastrous consequences. And yet mitochondria are also capable of much more. Work in diverse fields has led to the emergence of mitochondria as loci of control within a cell, at times acting as integrators of intracellular signals, while at others, they initiate or amplify signals, in turn. Specifically, mitochondria figure prominently in shaping two prominent signaling modalities within the cell, redox balance and protein phosphorylation cascades. In this minireview, we briefly consider intramitochondrial redox signaling with emphasis on nitrosylation and glutathionylation, as well as the growing evidence for the importance of protein phosphorylation by resident kinases. Finally, inspired by cell signaling literature outside the mitochondrion, we consider specific examples of cross-talk that may hint at a more extensive intramitochondrial redoxphosphorylation network.
Redox signaling in mitochondria
Reactive oxygen and nitrogen species
The redox balance within the cell results from the balance of pro-oxidant and anti-oxidant species. Mitochondrial superoxide (O2 -•) arises from the incomplete reduction of O 2 as a low-level byproduct of aerobic respiration; yields range from up to 1-2% of oxygen consumed by isolated mitochondria in vitro, though the yield is likely lower in vivo (St-Pierre et al. 2002; Turrens 2003) . Superoxide undergoes spontaneous dismutation to yield hydrogen peroxide (H 2 O 2 ), which can, in turn, decompose to generate reactive a hydroxyl radical (OH•) via the Fenton reaction. Collectively, O 2 (ROS). Respiratory complexes I and III have been implicated as prominent sites of mitochondrial ROS production. In the heart, a high proportion of superoxide is produced at the Q 0 site of complex III as a result of oxidation of the ubisemiquinone radical during the Q cycle (Brookes et al. 2004) . Excessive ROS production is often deleterious to mitochondrial and cell function. In particular, unchecked OH• accumulation leads to its indiscriminate reaction with proteins, lipids and DNA. ROS are, therefore, tightly monitored by scavenging enzymes. Superoxide from complex III is released into both the mitochondrial matrix, where it is converted to H 2 O 2 by manganese-dependent superoxide dismutase (MnSOD), and into the intermembrane space (IMS) where it is similarly reduced by copper/zinc-dependent superoxide dismutase (CuZnSOD). Hydrogen peroxide, in turn is quickly cleared (reduced to water) by the enzymes glutathione peroxidase, peroxiredoxins, and catalase.
In addition to ROS-scavenging enzymes, the cell is equipped with low molecular weight antioxidant molecules, the most abundant of which is the tripeptide, glutathione (γ-Glu-Cys-Gly). It is synthesized in the cytosol and transported to the mitochondria (Griffith and Meister 1985; Jocelyn 1975; Jocelyn and Kamminga 1974) , where its concentration has been estimated between 5 and 10 mM (Wahllander et al. 1979) . Upon oxidation, glutathione forms a cystine-linked dimer (GSSG). It is efficiently recycled to the reduced form through the action of NADPH-dependent glutathione reductase (GR), of which there are both cytosolic and mitochondrial isoforms. GR helps maintain the cellular GSH/GSSG ratio in the range of 30-100:1 (Hwang et al. 1992) . GSH participates as an antioxidant both by acting as a thiol buffer, directly reacting with protein thiols and ROS/RNS, and also by serving as a substrate for the glutathione peroxidases (Hurd et al. 2005a ) that reduce ROS.
The term, reactive nitrogen species (RNS) refers to the family of compounds derived from nitric oxide (NO•), the pleiotropic signaling molecule synthesized from L-arginine by the nitric oxide synthases, nNOS (NOS1), eNOS (NOS3) and iNOS (NOS2). In the heart, eNOS is found in the coronary vascular endothelium, while cardiac myocytes constitutively express eNOS and nNOS; iNOS expression can be triggered by inflammation, ischemia and heart failure (Brown and Borutaite 2007; Jones and Bolli 2006) . NO• exerts many of its physiological effects, including classical vasodilation, through a canonical pathway wherein it binds to guanylyl cyclase, thereby stimulating the formation of cyclic GMP from GTP, which subsequently activates PKG (Costa et al. 2008; Schlossmann et al. 2003 ). Yet NO• can also be converted, by oxidation or reduction, into many chemically reactive forms including nitrite ( 
Redox signaling
The term, "redox signaling" describes a process by which milder physiological levels of ROS/RNS induce modifications to proteins that are discrete, site-specific and reversible. Redox signals may abrogate or enhance activity of the target protein, and have been implicated in physiological signaling processes that include kinase signaling, channel function, apoptotic proteolysis, and regulation of transcription (Hool and Corry 2007; JanssenHeininger et al. 2008; Ueda et al. 2002) . The tenet of redox-sensing is that certain proteins undergo reversible chemical changes in response to changes in local redox potential. The sulfhydryl chemistry of cysteine residues within proteins is uniquely suited to the task, as they can adopt multiple oxidation states (Forman et al. 2004; Winterbourn and Hampton 2008) . Moreover, cysteines that are adjacent to basic amino acids or lie in a local hydrophobic pocket within a protein's tertiary structure are rendered particularly reactive at physiological pH, since these conditions lower the pKa of the thiol sidechain from 8 to between 5 and 7 (Greco et al. 2006; Hess et al. 2001 ). These reactive cysteines can react with ROS/RNS to yield a number of species including S-nitrosylated proteins (PSNO), intra-and intermolecular disulfide bonds (PS-SP), or the formation of mixed disulfides with glutathione (glutathionylation, PSSG) (Hurd et al. 2005a, b; JanssenHeininger et al. 2008 ).
S-nitrosylation
S-nitrosylation, the addition of NO• to reactive cysteines, has emerged as an important signaling modality, independently of the induction of cGMP production, effectively acting as a reversible molecular switch analogous to phosphorylation (Hess et al. 2005) . Owing to the complexity of NO• and thiol chemistry, there are many possible reaction mechanisms that can lead to Snitrosylation, though which prevails in vivo is still debated (Costa et al. 2003; Zhang and Hogg 2005) . Removal of the nitrosyl moiety can result from transnitrosation with GSH, which yields GSNO, whose accumulation is cleared by glutathione reductase. Alternately, nucleophilic attack by a
